Mirus
Mirus公司开发和制造用于生命科学研究的转染试剂,电穿孔解决方案和相关产品。
Mirus公司开发和制造用于生命科学研究的转染试剂,电穿孔解决方案和相关产品。
Mirus was founded on the principle that non-viral (i.e. plasmid DNA based) methods offer distinct advantages over viral methods of gene transfer. Our initial breakthrough in 1996 came with the development of a new type of transfection reagent that combined high efficiency delivery with low cellular toxicity: TransIT®-LT1 (Low Toxicity) Reagent remains the “gold standard” for broad-based gene delivery applications.
产品列表:
No. |
品牌 |
货号 |
名称 |
规格 |
1 |
Mirus |
MIR 6003 |
TransIT-X2® Dynamic Delivery System for Broad Spectrum Transfection |
0.3 mL |
2 |
Mirus |
MIR 2225 |
TransIT®-mRNA Transfection Kit |
0.4 mL |
3 |
Mirus |
MIR 2164 |
TransIT®-Oligo Transfection Reagent |
0.4 mL |
4 |
Mirus |
CHOgro® Expression System |
1 Kit |
|
5 |
Mirus |
MIR 6115 |
flashBAC™Baculovirus Expression System |
24 Reactions |
6 |
Mirus |
MIR 6150 |
pOET Insect and BacMam Transfer Plasmids |
20 µl (500 ng/µl) |
7 |
Mirus |
MIR 2904 |
TransIT-HeLaMONSTER® Transfection Kit |
0.4 mL |
8 |
Mirus |
MIR 2804 |
TransIT®-Keratinocyte Transfection Reagent |
0.4 mL |
9 |
Mirus |
MIR 5920 |
Selection Antibiotic Solutions |
10 ml (50 mg/ml in DI water) |
10 |
Mirus |
MIR 5960 |
Cell Culture Antibiotic Solutions |
1 x 100 ml |
11 |
Mirus |
MIR 6202 |
CHOgro® Expression Media |
1 L |
12 |
Mirus |
MIR 5210 |
TransIT®-QR Starter Kit |
10 injections |
13 |
Mirus |
MIR 6250 |
Human IgG1 Expression Control |
100 ug |
14 |
Mirus |
MIR 5520 |
pLIVE® Vector/lacZ Control Vector Kit |
20 µg of each vector |
15 |
Mirus |
MIR 7900 |
Label IT® RNAi Delivery Control, Cy®3 |
10 µg (0.75 nmol) |